These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11572660)

  • 1. Acute spinal cord injury: pharmacotherapy and drug development perspectives.
    Blight AR; Zimber MP
    Curr Opin Investig Drugs; 2001 Jun; 2(6):801-8. PubMed ID: 11572660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and pharmacologic treatment of acute spinal cord injury.
    Kwon BK; Tetzlaff W; Grauer JN; Beiner J; Vaccaro AR
    Spine J; 2004; 4(4):451-64. PubMed ID: 15246307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection after spinal cord injury: state of the science.
    Segatore M; Way C
    SCI Nurs; 1997 Mar; 14(1):8-18. PubMed ID: 9165951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the treatment of spinal cord injury.
    Baptiste DC; Fehlings MG
    Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacologic approaches to acute spinal cord injury.
    Rhoney DH; Luer MS; Hughes M; Hatton J
    Pharmacotherapy; 1996; 16(3):382-92. PubMed ID: 8726596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats.
    Yune TY; Lee JY; Cui CM; Kim HC; Oh TH
    J Neurochem; 2009 Aug; 110(4):1276-87. PubMed ID: 19519665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs for improving injury outcome in spinal cord injuries.
    Werner PC
    West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury.
    Kaptanoglu E; Solaroglu I; Surucu HS; Akbiyik F; Beskonakli E
    Acta Neurochir (Wien); 2005 Apr; 147(4):405-12; discussion 412. PubMed ID: 15696267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O; Solaroglu I; Beskonakli E; Taskin Y
    J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord.
    Greene KA; Marciano FF; Sonntag VK
    J Spinal Disord; 1996 Oct; 9(5):355-66. PubMed ID: 8938603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting spinal cord injury by pharmacological intervention.
    Priestley JV; Michael-Titus AT; Tetzlaff W
    Handb Clin Neurol; 2012; 109():463-84. PubMed ID: 23098731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-1 ganglioside and motor recovery following human spinal cord injury.
    Geisler FH
    J Emerg Med; 1993; 11 Suppl 1():49-55. PubMed ID: 8445203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats.
    Beril Gok H; Solaroglu I; Okutan O; Cimen B; Kaptanoglu E; Palaoglu S
    J Clin Neurosci; 2007 Feb; 14(2):138-42. PubMed ID: 17161287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for neuroprotection following spinal cord injury.
    Tederko P; Krasuski M; Kiwerski J; Nyka I; Białoszewski D
    Ortop Traumatol Rehabil; 2009; 11(2):103-10. PubMed ID: 19502667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury.
    Akdemir O; Uçankale M; Karaoğlan A; Barut S; Sağmanligil A; Bilguvar K; Cirakoğlu B; Sahan E; Colak A
    J Clin Neurosci; 2008 Oct; 15(10):1130-6. PubMed ID: 18656362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of clinical trials for acute spinal cord injury.
    Fehlings MG; Baptiste DC
    Injury; 2005 Jul; 36 Suppl 2():B113-22. PubMed ID: 15993112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Crit Care Nurs Q; 1999 Aug; 22(2):44-50. PubMed ID: 10646442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury.
    Citron BA; Arnold PM; Haynes NG; Ameenuddin S; Farooque M; Santacruz K; Festoff BW
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2269-77. PubMed ID: 18827691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.